High Prevalence of Weight Gain in Childhood Brain Tumor Survivors and Its Association With Hypothalamic-Pituitary Dysfunction
- 10 April 2021
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 39 (11), 1264-1273
- https://doi.org/10.1200/jco.20.01765
Abstract
Childhood brain tumor survivors (CBTS) are at risk for developing obesity, which negatively influences cardiometabolic health. The prevalence of obesity in CBTS may have been overestimated in previous cohorts because of inclusion of children with craniopharyngioma. On the contrary, the degree of weight gain may have been underestimated because of exclusion of CBTS who experienced weight gain, but were neither overweight nor obese. Weight gain may be an indicator of underlying hypothalamic-pituitary (HP) dysfunction. We aimed to study prevalence of and risk factors for significant weight gain, overweight, or obesity, and its association with HP dysfunction in a national cohort of noncraniopharyngioma and nonpituitary CBTS. Prevalence of and risk factors for significant weight gain (body mass index [BMI] change ≥ +2.0 standard deviation score [SDS]), overweight, or obesity at follow-up, and its association with HP dysfunction were studied in a nationwide cohort of CBTS, diagnosed in a 10-year period (2002-2012), excluding all craniopharyngioma and pituitary tumors. Of 661 CBTS, with a median age at follow-up of 7.3 years, 33.1% had significant weight gain, overweight, or obesity. Of the CBTS between 4 and 20 years of age, 28.7% were overweight or obese, compared with 13.2% of the general population between 4 and 20 years of age. BMI SDS at diagnosis, diagnosis of low-grade glioma, diabetes insipidus, and central precocious puberty were associated with weight gain, overweight, or obesity. The prevalence of HP dysfunction was higher in overweight and obese CTBS compared with normal-weight CBTS. Overweight, obesity, and significant weight gain are prevalent in CBTS. An increase in BMI during follow-up may be a reflection of HP dysfunction, necessitating more intense endocrine surveillance.This publication has 39 references indexed in Scilit:
- Tumor origin and growth pattern at diagnosis and surgical hypothalamic damage predict obesity in pediatric craniopharyngiomaJournal of Neuro-Oncology, 2013
- Risk Factors for Obesity in Adult Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor StudyJournal of Clinical Oncology, 2012
- Long‐term non‐cancer mortality in pediatric and young adult cancer survivors in FinlandPediatric Blood & Cancer, 2011
- Hypothalamic Obesity after Craniopharyngioma: Mechanisms, Diagnosis, and TreatmentFrontiers in Endocrinology, 2011
- Obesity and craniopharyngiomaItalian Journal of Pediatrics, 2011
- Physical performance limitations among adult survivors of childhood brain tumorsCancer, 2010
- Risk factors for obesity in childhood survivors of suprasellar brain tumours: a retrospective studyActa Paediatrica, 2010
- Endocrine Late Effects in Survivors of Pediatric Brain TumorsJournal of Pediatric Oncology Nursing, 2009
- Body mass index cut offs to define thinness in children and adolescents: international surveyBMJ, 2007
- Endocrine outcome in long‐term survivors of low‐grade hypothalamic/chiasmatic gliomaClinical Endocrinology, 1997